3H-digitoxin and polyethylene glycol (nonabsorbable marker) were given orally to five subjects provided with a gastrointestinal tube. Of the radioactivity administered, approximately 15, 30, and 70% had been absorbed when the test solution was passing the stomach, the duodenum, and the upper jejunum, respectively. The absorption was rapid, and the plasma contained detectable amounts of radioactivity after 5 minutes. There was no evidence of a disposition of 3H-digitoxin in intestinal aspirates. On a sixth subject labeled digitoxin was instilled in the mid-jejunum. The concentration of label in the plasma and the pattern of elimination of radioactivity in the urine and the feces in this subject indicated that the absorption of digitoxin was effective also in the more distal part of the gut. The combined results from the present study indicate that the absorption of orally administered digitoxin is complete.
T HE gastrointestinal absorption of digitoxin is considered to be very effective since the oral and parenteral dose required for therapeutic effects is about the same.' By such calculations the absorption of digoxin has been estimated to approximate 70%. 2 3 Studies in animals have demonstrated that digitoxin and digoxin participate in an enterohepatic circulation.4 It is possible that gastric and intestinal diseases may interfere with the absorption of not only the orally administered glycosides but also of the glycosides and their metabolites that are excreted with the bile. Goldfinger et al. 5 recently reported that the plasma concentration of digoxin is significantly lower in patients with malabsorption. This observation underlines the importance of a more extensive knowledge of the gastrointestinal absorption and the metabolic fate of orally administered digitalis glycosides in healthy and diseased subjects.
The main purpose of the present investigation was to study which parts of the gastrointestinal tract are involved in the absorption of orally administered digitoxin in healthy subjects. An attempt was also made to evaluate to what extent digitoxin participates in the enterohepatic circulation. 3H-digitoxin was given orally to five subjects, by intrajejunal instillation to a sixth, and intravenously to a seventh (table 1). The oral dose (50 uCi) was dissolved in 50 ml water together with 0.1 mg nonlabeled digitoxin and 5 g polyethylene glycol (PEG, nonabsorbable marker). The intake of the test solution was immediately followed by 100 ml water. When instilled intrajejunally, the same amount of labeled and nonlabeled digitoxin was dissolved in 10 ml 5.5% glucose and injected as a bolus. The intravenous dose (3.5 ,uCi mixed with 0.1 mg nonlabeled digitoxin) was dissolved in 3.5 ml 11% ethanol. The experiments were started in the morning before breakfast, with the subjects having fasted overnight.
ABSORPTION OF 3H-DIGITOXIN
Before the experiments the subjects were provided with an intestinal double-lumen tube that was inserted through the nose and allowed to pass to the desired level. The position of the tube was controlled by X-ray. Gastric aspirates were obtained through a separate tube.
Gastrointestinal aspirates were drawn at various time intervals during 24 hours and analyzed for total radioactivity, PEG, and bilirubin. In some instances the label in chloroform extracts of the aspirates was fractionated by paper chromatography. To obtain concentrated bile, 37. Material* 3H-digitoxin (specific activity 4.5 Ci/mmole according to the manufacturer), the radioactivity randomly distributed, was purified on the day before each experiment by thin-layer chromatography on glass plates (20 x 20 cm) covered with a layer (250 ,u) of silica gel. Ethyl-acetatebutanol (90:10, v/v) was used as the solvent system.6 The label with the same Rf-value as that of unlabeled digitoxin was recovered by subsequent extraction with ethanol of the gel that had been scraped off the plate. On refractionation by descending paper chromatography (see below), more than 99% of the label accumulated within the same spot as unlabeled digitoxin.
Determination of Radioactivity
All determinations of radioactivity were performed with a liquid scintillator (model 3003t). Plasma samples (1 ml) were dissolved in 15 ml of an emulsifier (Insta-Gelt). Aliquots of gastrointestinal aspirates (0.1 ml) and urine (1 ml) were pipetted into 15 ml of the scintillation liquid, as 0.77. The lowest A/T ratios (0.16 to 0.42) were found in the aspirates that were drawn from the proximal jejunum of four subjects. The A/T ratios, as well as the concentration of label and PEG in aspirates at various levels from subject R.W., are shown in figure 1 .
Some duodenal aspirates, obtained when the major part of the radioactivity and PEG was passing, were analyzed with regard to content of "3H-digitoxin." All radioactivity was extractable with chloroform; 97 to 98% of the label from the paper chromatograms had the same Rf-value as that of unlabeled digitoxin. administration of the test solution that time the plasma volume cont; 20% of the administered dose. The tion of radioactivity decreased rap the next few hours. When calculated from the fourth hour to the twenty-first day, the halflife of the label was approximately 13 days.
All radioactivity in serum samples collected 30 min to 15 days after the administration of the test solution could be extracted with chloroform. In one sample, collected on the twenty-first day, 15% of the label remained in the methanol-water phase. Paper chromatography of the chloroform extracts from specimens obtained within 2 days showed that more than 80% of the radioactivity was accumulated within the digitoxin area. From 6 to 21 days the proportion of label with an Rfvalue below digitoxin became more prominent, and "3H-digitoxin" constituted approximately 55% of the label ( fig. 3 ).
Biliary Excretion of Label
The major part of the test solution passed the duodenum within 30 min. In one subject who received an injection of cholecystokinin at 1 hour, the concentration of label was higher in the aspirate obtained before rather than after the stimulation of the flow of bile. After 2.5 hours, however, the same procedure resulted in more than a tenfold increase of the label, which had a concentration of 11,700 cpm/mg bilirubin.
The mean concentration of radioactivity from 2.5 to 24 hours in this subject was 5 (table 3) .
The radioactivity with the same Rf-value as digitoxin constituted 53% of the total label from a urinary specimen obtained at 6 hours The corresponding figure for urinary specimens collected from 2 to 21 days was 20 to 38%.
The cumulative excretion of label in the feces for 21 days was 23 (19 to 25)% of the given dose. The water that condensed during lyophilization of the fecal homogenates contained 0.1% of the label recovered in feces.
Intrajejunal Instillation
The concentration of label in plasma was lower after intrajejunal instillation than after oral administration (fig. 2) The plasma radioactivity curve is shown in figure 2 . From 4 hours to 21 days the half-life of the label was 9 days. Duodenal aspirates were drawn at various times from 1 to 24 hours. The concentration of radioactivity varied between 127 and 462, the mean value being 290 cpm/mg bilirubin. The biliary excretion of label during the first 24 hours was estimated to be 4.9%. In this subject the cumulative excretion of label in urine ( fig. 4) and feces amount to 43 and 26%, respectively.
Discussion
The present technic of calculating the uptake of digitoxin in the upper small intestine is based on the assumption that 3H-digitoxin does not undergo decomposition before being absorbed and that the label remains attached to the molecule. The possibility of such changes was tested by analyses of the gastrointestinal aspirates when the test solution passed the stomach and the upper small intestine. Since 97 to 98% of the label in these aspirates had the same paper chromatographic properties as digitoxin, it is most likely that the absorption of label was reflecting the uptake of the glycoside.
The absorption of digitoxin, when administered orally in a water solution, was very rapid, as indicated by the appearance of radioactivity in plasma after only 5 min, and was effective, as demonstrated by the A/T ratios at various levels in the gastrointestinal tract. Fifteen per cent of the given dose had been absorbed when the test solution was passing the stomach. The absorption continued in the duodenum and the very proximal part of the jejunum, at which level approximately 70% of the label had been taken up ( fig. 5 ). The low excretion of radioactivity in feces during the first days of these experiments indicates that digitoxin is effectively taken up, even in the jejunum and/or the ileum. This view is further supported by the observation of the similarity in plasma concentration of label and in the fecal and urinary excretion of radioactivity after oral and intrajejunal administration. From the combined results of these studies, it appears that the absorption of orally administered digitoxin should be complete.
In the interpretations of the data concerning the radioactivity in blood, bile, urine, and feces, it is essential to consider that the original compound was labeled randomly. As much as 67% of the tritium in the molecule can be associated with the digitoxose residues and only 33% with the genin.14 Since tritium in a molecule may be replaced by hydrogen in the body,'5 the total radioactivity in any tissue or excreta may represent a mixture of the label in digitoxin, its metabolites, and other substances not derived from the parent compound. The magnitude of this latter fraction was not established. The radioactivity in digitoxin was measured on paper chromatography of a chloroform extract that had passed a silicic acid column procedure which should have removed most of the nonrelevant radioactivity.
After a 4-hour period of equilibration of the label in the body, the half-life of the plasma radioactivity was about 13 A biliary excretion of radioactivity after the administration of various labeled glycosides of digitalis to animals provided with a bile duct fistula has been reported by several authors. 4 Okita suggests that the long half-life of digitoxin compared with that of digoxin is due to an extensive enterohepatic circulation. The importance of such a circulation was also stressed by Katzung and Meyers,20 who found that 39% of the label of 3H-digitoxin intravenously administered to dogs was eliminated through a bile duct fistula within 8 hours.
The half-life of the plasma label in these dogs was 6 hours, whereas it amounted to 14 hours in control sham-operated animals. Katzung and Meyers21 suggested that aspiration of duodenal bile might be an effective way to eliminate digitoxin in an acutely intoxicated patient. However, the enterohepatic circulation of digitoxin shows large species variation and appears to be smaller in man than in dogs. The calculated biliary excretion of label in the present subjects was in all instances less than 10%, and it seems less likely that the enterohepatic circulation is a good explanation for the long retention of digitoxin in man.
The metabolism of digitoxin has been studied by several authors.22 24 The lactone may be saturated. There is a stepwise hydrolysis of the trisaccharide portion to bidigitoxoside, monodigitoxoside, and the genin. Any of these compounds may be hydroxylated at the 12 8-position. This results in the formation of digoxin out of digitoxin. The inactive 3 a-hydroxy epimer of the genins is formed in the liver. The a-hydroxylated compounds may be conjugated with glucturonic or sulfuric acid. With the technic used in the present study, it was not possible to get detailed information about the metabolic pathways of the glycoside. However, the pattern of distribution of the label on solvent partition column and paper chromatography may give some hints. Digitoxin, digitoxigenin, and the nonconjugated derivatives of these compounds should accumulate in the chloroform phase during the extraction procedures employed. The radioactivity in all but one of the plasma samples and in all duodenal aspirates obtained within 1 hour was extractable with chloroform ( fig. 6 ). The chloroform fraction of duodenal aspirates obtained on later occasions contained proportionally less radioactivity. In specimens of duodenal bile collected after injection of cholecystokinin at 7 and 24 hours, only 60% of the label was extractable with chloroform ( fig. 6) . Part of the labeled compound(s) in urine appeared to be conjugated with glucuronic acid. The nature of these compounds was not established. It is interesting to note that Lukas and Peterson were unable to find digitoxin glucuronide in the urine of patients treated with digitoxin.14 The chloroform extract was further fractionated by paper chromatography by which digitoxin, digoxin, digitoxigenin, and digoxigenin could be separated. Because of the possible contamination of other radioactive compounds, the label within each segment represents a maximal concentration of the corresponding compound. By using this definition for identification, the amount of "nonmetaholized" digitoxin was proportionally higher in the blood than in the duodenal bile and the urine (fig. 6 ). The label that accumulated within the segments of digoxin, digitoxigenin, and digoxigenin in all three types of specimens varied among the subjects, although not consistently. The combined amount of label with the same Rf-value as these three metabolites ranged between 10 and 15%.
